Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory Epilepsy Receiving Adjunctive Levetiracetam Therapy

BACKGROUND AND PURPOSE: Levetiracetam (LEV) is a new antiepileptic drug that has been found to be effective as an adjunctive therapy for uncontrolled partial seizures. However, the results of several studies suggested that LEV has negative psychotropic effects, including irritability, aggressiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jang-Joon, Song, Hyun-Seok, Hwang, Yang-Ha, Lee, Ho-Won, Suh, Chung-Kyu, Park, Sung-Pa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212598/
https://www.ncbi.nlm.nih.gov/pubmed/22087206
http://dx.doi.org/10.3988/jcn.2011.7.3.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212598/
https://www.ncbi.nlm.nih.gov/pubmed/22087206
http://dx.doi.org/10.3988/jcn.2011.7.3.128

Ejemplares similares